Illumina launches cancer profiling diagnostic in Europe
The DNA sequencing giant Illumina has launched a new in vitro diagnostic test in Europe designed to profile various cancer mutations and help direct patients to targeted therapies.
Stay updated with breaking news from Genomic Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The DNA sequencing giant Illumina has launched a new in vitro diagnostic test in Europe designed to profile various cancer mutations and help direct patients to targeted therapies.
Precision medicine company Variantyx pulled in $41.5 million for its advanced genomic testing platform, with plans to target growth in precision oncology.
Amid the “hidden pandemic" of antibiotic-resistant infections, Day Zero Diagnostics is doubling down on its mission of developing tools to identify and profile those bacterial diseases as early as possible.
For the first time since genomic analysis of Covid-19 became widespread, a single variant is responsible for all cases sampled, scientists have revealed.
Civil Aviation Minister Jyotiraditya Scindia said the situation is being closely monitored in consultation with other ministries regarding